Overview


Anxiety treatment devices refer to a wide range of devices and technologies designed to help individuals manage and relieve symptoms of anxiety disorders. They range from simple tools to sophisticated electronic devices, and they often aim to promote relaxation and mindfulness or provide a sense of control over anxiety. These devices are typically non-invasive and can be used as an alternative to traditional therapy and medication. These devices often utilize various methods, such as mindfulness techniques, biofeedback, sensory stimulation, or cognitive behavioral therapy (CBT) principles. They can be used in clinical settings under the advice of a healthcare specialist or at home as a self-help tool.

Two well-known anxiety treatment devices that operate on different principles are the alpha-stim and fisher wallace stimulator. Alpha-Stim is a cranial electrotherapy stimulation (CES) device. It delivers microcurrents of electricity directly to the brain via small electrodes placed on the earlobes. The device works by modulating the brain's electrical action. It's believed to increase alpha brain waves and decrease delta and theta waves, which can facilitate a state of calmness and relaxation. It treats various conditions, including anxiety, depression, insomnia, and pain. Also, the fisher wallace stimulator is another cranial electrotherapy stimulation (CES) device. It also delivers microcurrents to the brain, typically through electrodes placed on the forehead. Like alpha-stim, the fisher-wallace stimulator aims to modulate brain wave activity. It's designed to promote the production of serotonin, melatonin, and other neurotransmitters related to mood and sleep.

FutureWise Market Research has published a report that provides an insightful analysis anxiety treatment devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts anxiety treatment devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Allevia Health, Inc
  • Fisher Wallace Laboratories, LLC
  • Electromedical Products International, Inc
  • Mind Alive Inc
  • Bharat Medical Systems

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Anxiety Treatment Devices Market:

  • In May 2021, VisataGen Therapeutics Inc. initiated the PALISADE Phase-2 clinical program, which includes the PALISADE-a phase 3 trial. This trial is a randomized, double-blind, placebo-controlled study to assess the effectiveness and safety of an acute anxiety treatment for individuals diagnosed with social anxiety disorder (SAD).

The rising incidences of anxiety disorders worldwide emphasize the urgent need for accessible and effective treatment solutions. With a growing awareness and improved understanding of these conditions, there's a surge in demand for innovative interventions. Anxiety treatment devices, offering non-invasive and drug-free alternatives, are positioned at the forefront of this paradigm shift in mental healthcare. Their appeal lies in their capability to provide practical, self-manageable solutions, aligning with a general societal trend towards empowering individuals in their well-being. This growing recognition, advancements in technology, and a shift towards holistic mental health care propel the demand for anxiety treatment devices as an integral component of modern mental health treatment. Moreover, the preference for non-pharmaceutical interventions in anxiety treatment originates from a growing awareness of potential liabilities associated with medication. Concerns about side effects and the risk of dependency have led many individuals to seek alternative approaches. Devices offering non-invasive and drug-free solutions offer an attractive choice for patients and healthcare experts. They provide a safe and effective means of managing anxiety, aligning with a broader shift towards holistic and personalized approaches to mental health care, further driving the target market. Also, the increasing adoption of digital technologies, including telemedicine and mobile health apps, represents a significant trend in healthcare market. Telemedicine facilitates remote consultations, providing timely access to mental health services, especially for those in developing areas or with mobility constraints. Mobile health apps offer a wide array of resources, from mindfulness exercises to symptom trackers, enabling users to actively engage in their mental well-being. However, limited awareness and knowledge among healthcare professionals and the general public regarding the availability and advantages of anxiety treatment devices pose a significant restraint in the market. Many individuals may be unaware that such devices exist or may not fully understand their potential benefits in managing anxiety. This lack of knowledge may lead to underutilization and a choice for more traditional treatment methods, potentially restricting those requiring a potentially effective alternative.

By Device Type

  • Alpha Stim
  • Fisher Wallace
  • Other Anxiety Treatment Devices

By Indication

  • Panic Disorder
  • Obsessive Compulsive Disorder
  • Post-Traumatic Stress Disorder
  • Special Phobias
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Trauma Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to factors such as the availability of numerous branded formulations, growing incidence of anxiety and depression, increasing healthcare awareness regarding mental health, increasing geriatric population, increasing number of hospitals and trauma centres, technological advancements and advanced treatment procedures in the area are likely to propel the market growth during the forecast period. Additionally, the increasing number of product launches, high disposable income, increasing number of prescriptions for antidepressants, the growing availability of online therapy services, and increasing usage of digital technologies such as telemedicine and mobile health apps in the US are anticipated to drive the growth of anxiety treatment devices market during the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anxiety Treatment Devices Market By Device Type, By Indication, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anxiety Treatment Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anxiety Treatment Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anxiety Treatment Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anxiety Treatment Devices Market, By Device Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Alpha Stim
        2. Fisher Wallace
        3. Other Anxiety Treatment Devices

  • 8.   Anxiety Treatment Devices Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Panic Disorder
        2. Obsessive Compulsive Disorder
        3. Post-Traumatic Stress Disorder
        4. Special Phobias
        5. Others

  • 9.   Anxiety Treatment Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Specialty Clinics
        3. Trauma Centers

  • 10.   North America Anxiety Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Anxiety Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Anxiety Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Anxiety Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Allevia Health, Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Fisher Wallace Laboratories, LLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Electromedical Products International, Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Mind Alive Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bharat Medical Systems
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Anxiety Disorder Treatment Market

Read More

Anxiety Disorders and Depression Treatment Market

Read More
Partner

Our Clients